Yi Yuan
Shanghai University
12 Papers
33 Citations
Yi Yuan is an academic researcher from Shanghai University. The author has contributed to research in topics: Bufalin & Prodrug. The author has an hindex of 2, co-authored 8 publications.
Chat about Author
Papers
Viola yedoensis Makino formula alleviates DNCB-induced atopic dermatitis by activating JAK2/STAT3 signaling pathway and promoting M2 macrophages polarization.
Hairong Zeng,Bei Zhao,Die Zhang,Xinmiao Rui,Xudong Hou,Xingxing Chen,B. Zhang,Yi Yuan,Hongping Deng,Guang-Bo Ge +9 more
TL;DR: Wang et al. as discussed by the authors investigated the therapeutic effects of VYAC on DNCB-induced atopic dermatitis (AD) and elucidated the underlying anti-inflammatory mechanisms.
36
Polymeric prodrug of bufalin for increasing solubility and stability: Synthesis and anticancer study in vitro and in vivo.
TL;DR: A novel poly(ethylene glycol) (PEG)-based polymeric prodrug of BUF is fabricated to improve its water solubility and stability at the prerequisite of maintaining its original anticancer activity.
31
Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo
TL;DR: It is indicated that polymeric prodrug of BUF holds promising potential toward the treatment of somatostatin receptor 2 overexpressing breast cancer.
Folic Acid–Functionalized Metal-Organic Framework Nanoparticles as Drug Carriers Improved Bufalin Antitumor Activity Against Breast Cancer
TL;DR: FA-MOF could be developed as a potential delivery system for Buf to improve its antitumor activity for breast cancer treatment and displayed improved accumulation in the tumor site, enhanced anticancer activity, and reduced side effects in vivo.
22
A TCM formula VYAC ameliorates DNCB-induced atopic dermatitis via blocking mast cell degranulation and suppressing NF-κB pathway
Hai Rong Zeng,Bei Zhao,Xing Rui,Gui Hua Jia,Yue Wu,Die Zhang,Hao Nao Yu,Ben Rui Zhang,Yi Yuan +8 more
TL;DR: Wang et al. as discussed by the authors investigated the therapeutic effects of VYAC on the 2,4-dinitrobenzene (DNCB) induced atopic dermatitis (AD)-like mice and explored the underlying mechanisms.
15